2025³â 08¿ù 08ÀÏ ±Ý¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92587°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...

GS25 ¡®»ý°úÀÏ ½º¹«µð¡¯ ¿î¿µÁ¡ ±âÁØ Àüü ÆÇ¸Å·® 3À§

2030 ¼¼´ë°¡ °í°´ 69.5%
GS25°¡ ¾÷°è ÃÖÃÊ·Î ¼±º¸ÀÎ »ý°úÀÏ ½º¹«µð Àü¿ë ±â±â GS¸®Å×ÀÏÀÌ ¿î¿µÇÏ´Â ÆíÀÇÁ¡ GS25°¡ º»°ÝÀûÀÎ ¹«´õÀ§¸¦ ¸Â¾Æ ÃÖ±Ù 2ÁÖ°£(6/23~7/6) ‘»ý°úÀÏ ½º¹«µð’ ¿î¿µ Á¡Æ÷ 20¿© °÷À» ´ë»óÀ¸·Î ÆÇ¸Å µ¥ÀÌÅ͸¦ ºÐ¼®ÇÑ °á°ú »ý°úÀÏ ½º¹«µð°¡ ‘Ä«Æä25 ¾Æ¸Þ¸®Ä«³ë’, ‘ÄÅ ¾óÀ½’¿¡ À̾î Àüü ÆÇ¸Å·® 3À§(´ã¹è Á¦¿Ü)¿¡ µî±ØÇÑ °ÍÀ¸·Î ºÐ¼®µÆ´Ù. GS25´Â Áö³­ÇØ 12¿ù ÆíÀÇÁ¡ ¾÷°è ÃÖÃÊ·Î Á÷¿µÁ¡ ÇѰ÷À» ÅëÇØ Áï¼® »ý°úÀÏ ½º¹«µð¸¦ ¼±º¸¿´´Ù. ÃֽŠ¸Ô°Å¸® Æ®·»µå¸¦ ¼±Á¡ÇϰíÀÚ ÆíÀÇÁ¡ Ư¼º¿¡ ¸Â´Â Àü¿ë ±â±â ...
¡®¸Ôº¸Çü¡¯ ±èÁØÇö vs ¹®¼¼À±, ¡®¸Ô¼±¼ö¡¯ ³×¹ö¿£µù ¸Ô¹æ ¡®¿¬Àå... (2024-04-29)
°¶·°½Ã üÇè °ø°£ ¡®°¶·°½Ã ÀͽºÇǸ®¾ð½º ½ºÆäÀ̽º¡¯ ¿ÀÇ (2024-07-10)
»ï¼º¹ÙÀÌ¿À·ÎÁ÷½º, 1.46Á¶¿ø ¿ª´ë ÃÖ´ë ±Ô¸ð ¼öÁÖ °è¾à (2024-07-03)
Phenomenal Digital Transformation Delivery for MTN South Sud... (2023-10-12)
Hong Kong Invites Global Travellers to Discover the City¡¯s ... (2023-09-21)
»ùÇ¥ ¡®¾³¾³½Ï½Ï ¹äµµµÏ¡¯ Á¦Ç° 3Á¾ Ãâ½Ã (2024-03-11)
Kiwibank Goes Live with ACI Worldwide's Enterprise Payments ... (2024-03-11)
³ëÀÎ µ¹º½ »ê¾÷ ¼ºÀå... ´õ ¸¹Àº ÀÚ±Ý À¯ÀÔ ±â´ë (2023-12-09)
¿ìÁÖ¿¡¼­ ½Å¼ÒÀç žçÀüÁö °ËÁõ ³ª¼±´Ù (2024-05-15)
GS25, °¡Á¤ÀÇ ´Þ ¸Â¾Æ ¼ø±Ý Ä«³×À̼ǡ¤Â÷º°È­ ¿Ï±¸ ¼±ºÄ (2024-05-01)
The Access Group Fast Tracks Expansion Plans in APAC Partner... (2023-06-15)
NielsenIQ Mid-Year Consumer Outlook: Guide to 2025 Reveals C... (2024-10-13)
NIKE, Inc. Board of Directors Announces Long-Time Nike Veter... (2024-09-29)
¡®³ª´Â SOLO¡¯ 20±â ±¤¼ö, ÀÏ»ýÀÏ´ë °á½ÉÇÑ ·Î¸Ç½º ½ÂºÎ»ç? (2024-06-07)
ÇÑÈ­Å¥¼¿ ¡®¼Ö¶ó Çãºê¡¯ Ä«Åͽººô ½Å °øÀå °¡µ¿ °³½Ã (2024-05-17)
GS¼¥, ¾Æ¸ð·¹ÆÛ½ÃÇȰú 5ÀÏ ¿¬¼Ó ¶óÀ̺ê Ä¿¸Ó½º ƯÁý (2024-05-10)
NIQ Report Highlights Top Trends Shaping Tech & Durables Spe... (2024-11-26)
ÆÒ´ýÀÇ ¼±ÇÑ´öÁú, »õ·Î¿öÁö´Â ÀÚ¿øºÀ»ç (2024-06-09)
¡®À§ÀåÃë¾÷¡¯ ½Å±â·ç, ¡°³ª Á·¹ß Æ®¶ó¿ì¸¶ Àִµ¥..¡± (2023-08-16)
Á¶ÇÑö, ¡®ºñ¹ÐÀº ¾ø¾î¡¯ Ưº°Ã⿬... º¸´Â Àç¹Ì ´õÇß´Ù (2024-05-12)
¡®·¹ÀÌÆ®¶ó¡¯, ´ëÇѹα¹ °ü±¤±â³äǰ ¹Ú¶÷ȸ Âü°¡ (2023-11-24)
Sound Vaccine Secures KRW 180,000,000,000 Capital Commitment... (2023-06-14)
Quectel Broadens RedCap Offering With Commercial Availabilit... (2024-04-14)
¿¡Æ¼¿ÀÇÇ¾Æ Ç×°ø, Çѱ¹-¾ÆÇÁ¸®Ä« Á÷Ç× ³ë¼± ÁõÆí (2023-10-06)
Itron Unveils New Brand Identity, Ushering in New Era of Gri... (2024-02-18)
       [ÀÌÀü][1]....[647][648][649][650][651][652][653][654][655]...[3704][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..